FMTO - U.S. Patent and Trademark Office Granted Femto Technologies Inc. A Notice of Allowance for Use of its Sensera design
(TheNewswire)
Nasdaq-Listed Femtech Innovator, creator of Sensera, AdvancesAI-Driven Feminine Wellness Solutions
Los Angeles, California – May 13, 2025 – TheNewswire - FemtoTechnologies Inc. (Nasdaq: FMTO), apioneering Femtech company formerly known as BYND CannasoftEnterprises Inc., announced today that the U.S. Patent and TrademarkOffice (USPTO) has granted it a Notice of Allowance for its female treatment device – sensera design. Thismilestone reinforces Femto’s commitment to redefining wellnesssolutions through AI-driven advancements.
The unique design of the Sensera device is a fundamental component ofFemto’s innovative Femtech products, which was recently recognizedas a CES Innovation Awards® 2025 honoree in the AI category. Thisprestigious accolade underscores Femto’s leadership in cutting-edgetechnology tailored to enhance wellness for all.
"Receiving the Notice of Allowance from the U.S. Patent andTrademark Office marks another significant milestone for FemtoTechnologies. Our proprietary Smart Release System technology alongwith the cutting-edge design is at the forefront of innovation,driving transformative advancements in Femtech. This recognitionreinforces our commitment to pioneering AI-driven wellness solutionsthat enhance lives globally." – Yftah Ben Yaackov, CEO, FemtoTechnologies Inc.
Femto’s R&D initiatives and product development are heavilydriven by its SRS technology with applications spanning a variety ofFemtech solutions. The company remains committed to rigorous testing,research, and regulatory compliance to ensure the efficacy and safetyof its products.
About Femto Technologies Inc.
Femto Technologies Inc. (Nasdaq: FMTO) is a cutting-edge Femtechcompany spearheading transformative advancements in wellnesstechnology. With a strong emphasis on AI-driven solutions, Femto isdedicated to innovating products that enhance well-being throughintelligent technology integration.
ABOUT SENSERA
Sensera is a feminine wellness device on a mission tobridge the gap between feminine pleasure and wellness, providing aholistic self-care experience that adapts to a woman’s changingneeds. Sensera utilizes Femto’s proprietary Smart Release System(SRS) technology, including machine learning and AI, to enhancefeminine wellness. Sensera is a CES Innovation Awards® 2025 Honoraryin the AI category.
For more information on Sensera, please visit www.senserawellness.com and followus on Instagram , , and .
MEDIA CONTACT
For product demonstration andmedia
Samantha Breen
Opportunity PR (for Sensera)
+1 949.290.2834
COMPANY CONTACT
Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e?mail: ir@femtocorp.com
Cautionary NoteRegarding Forward-Looking Statements
This press release includes certain statements that maybe deemed “forward-looking statements” within the meaning ofSection 27A of the U.S. Securities Act of 1933, as amended, andSection 21E of the U.S. Securities Exchange Act of 1934, as amendedand under Canadian securities laws. When used in this press release,the words “may”, “would”, “could”, “will”,“intend”, “plan”, “anticipate”, “believe”,“estimate”, “expect” and similar expressions are intended toidentify forward?looking statements. Such statements are subject tocertain risks and uncertainties, and actual circumstances, events orresults may differ materially from those projected in suchforward-looking statements.
Although the Company believes the expectationsexpressed in such forward-looking statements are based on reasonableassumptions, such statements are not guarantees of future performance,and actual events or developments may differ materially from those inforward-looking statements. Such forward-looking statementsnecessarily involve known and unknown risks and uncertainties, whichmay cause the Company’s actual performance and financial results infuture periods to differ materially from any projections of futureperformance or results expressed or implied by such forward-lookingstatements. Such statements reflect the Company's current views withrespect to future events and are subject to such risks anduncertainties. Many factors could cause actual results to differmaterially from the statements made, including future financialperformance, unanticipated regulatory requests and delays, finalpatents approval, and those factors discussed in filings made by thecompany with the Canadian securities regulatory authorities, including(without limitation) in the company's management's discussion andanalysis for the year ended December 31, 2024 and annual informationform dated March 31, 2025, which are available under the company'sprofile at www.sedarplus.ca, and in the Company’s Annual Report onForm 20-F for the year then ended that was filed with the U.S.Securities and Exchange Commission on March 31, 2025. Should one ormore of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect,actual results may vary materially from those described herein asintended, planned, anticipated, or expected. We do not intend and donot assume any obligation to update these forward?lookingstatements, except as required by law. Any such forward-lookingstatements represent management's estimates as of the date of thispress release. While we may elect to update such forward-lookingstatements at some point in the future, we disclaim any obligation todo so, even if subsequent events cause our views to change.Shareholders are cautioned not to put undue reliance on suchforward?looking statements.
Copyright (c) 2025 TheNewswire - All rights reserved.